Money, brains and ambition: Third Rock startup Tango launches with $55M and a stellar crew of scientific advisers
Tango Therapeutics meets all the criteria you’ve come to expect from a Third Rock startup.
There’s the $55 million round advanced to recruit a team and reach tangible development goals while looking to blaze a new trail in the realm of unmet medical needs. There are the Third Rock partners taking interim roles to get everything up and running. And there’s an impressive crew of scientific advisers who bring together decades of lab work involving the challenges this company will face.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.